Dulcolax 5 mg Tablets Recalled for Improper Storage Conditions
Dulcolax 5 mg tablets distributed to Family Dollar Stores between April 30 and June 10, 2022 are recalled because they were stored outside appropriate temperature conditions, which could affect product effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for CGMP storage deviation. No illnesses or injuries have been reported. The hazard is potential loss of product efficacy due to improper storage conditions, which is a quality issue rather than a direct safety threat.
Plain-English summary
Dulcolax 5 mg tablets in 25-count boxes distributed to specific Family Dollar Store locations between April 30, 2022 and June 10, 2022 (SKU 916079) are being recalled.
The product was stored outside appropriate temperature conditions in violation of current good manufacturing practices (CGMP). This could affect the product's potency and effectiveness.
Consumers who purchased the affected product should stop using it. Contact the store or pharmacy where you purchased the product for information about returns or replacements.
The recalled product
- Product
- DULCOLAX 5 MG TABLET 25 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 916079
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01